As a model, we utilized the RPMI 8226 multiple myeloma cell line, which lacks expression of mesothelin and CD19 (Supplementary Fig. 3a, b) and has moderate expression levels of MUC1 (Fig. 3b). This evidence concerns the gene MSLN and plasma cell myeloma.